The Alliance at IAS 2015

Join us at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, 19–22 July 2015 | Vancouver, Canada

With 6,000 HIV professionals in attendance, it is the largest global scientific conference on HIV and AIDS.

In attendance:

Dr Gitau Mburu, International Secretariat, UK
Tetyana Deshko and Maistat Ludmila, International HIV/AIDS Alliance in Ukraine
Dr Siyan Yi, KHANA (Cambodia)
Sonal Mehta, Viswanathan Arumugam and James Robertson, India HIV/AIDS Alliance
Dr Robinson Cabello and Dr Isaac Alva, Via Libre (Peru)
Dr Elena Obieta, Key Correspondent

Poster and oral abstracts: 

All posters will be displayed in the Poster Exhibition, West Exhibition Level, Monday 20 - Wednesday 22 July, 10:00-18:30.  See below for specific days/times when Alliance colleagues will be available to answer questions.

GLOBAL

  • Impact of opioid substitution therapy on antiretroviral therapy: a systematic review and meta-analysis (Bristol University & London School of Hygiene and Tropical Medicine with the International HIV/AIDS Alliance)

CAMBODIA

  • AIDS-related stigma and discrimination in relationship with mental disorders among people living with HIV: a cross-sectional study in Cambodia, 22 July, 12.30-14.30, Exhibition Hall B, West Exhibition Level.
  • The impact of integrating HIV and sexual reproductive health services on health and healthcare-seeking behavior of female entertainment workers in Cambodia 
  • National size estimation of people who use drugs using capture-recapture method in nine provinces of Cambodia, 21 July, 12.30-14.30 at Exhibition Hall B, West Exhibition Level.
  • Peer-provided HIV counselling and testing for key populations in Cambodia: lessons learnt and implications for service delivery, 21 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level.

INDIA

  • Feasibility of supervised self-testing using an oral fluid-based HIV rapid testing method among pregnant women in rural India, 21 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level
  • Awareness, utilization and access to HIV and maternal health care services for pregnant women in two high HIV prevalence districts of India: a baseline evaluation, 20 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level
  • Engaging frontline community health workers to provide oral rapid HIV testing to pregnant women in rural India, 21 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level
  • Impact of harm reduction interventions under the community action on harm reduction "Hridaya" programme on safe injecting and sexual behaviours among people who inject drugs in India, 20 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level
  • Association of condom use with changing sexual roles among MSM, transgenders and hijras in India: findings from the midline study of the Global Fund-supported Pehchan programme, 22 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level
  • More vulnerability, more risk: findings from a cross-sectional qualitative study on the multiple vulnerabilities experienced by people who inject drugs (PWID) in Bihar and Manipur, India, 21 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level
  • Reach them early: identifying risk behaviours after onset of injecting to reduce sharing of injecting equipment: findings from the Hridaya drug use pattern assessment in India, 21 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level

PERU

  • Acceptability of internet and cell-phone messages to promote linkage to HIV care, 20 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level
  • Attitudes and preferences about cervical cancer screening among women living with HIV in Peru, 21 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level

UGANDA

  • Ongoing HIV transmission risks and factors associated with HIV transmission risks among young people living with HIV in Uganda (presented by Brady Zieman, Population Council, consortium partners in the Link Up project), 21 July, 112:30-14:30, Exhibition Hall B, West Exhibition Level

UKRAINE

  • Effective services for HIV prevention among people who inject drugs (PWIDs) in Ukraine, 21 July 12:30-14:30, Exhibition Hall B, West Exhibition Level
  • Early exits from the opioid substitution treatment (OST) in Ukraine: reasons and possible explanation
  • Need for improved testing: HIV testing patterns among female sex workers in Ukraine
  • Cohort study as a comprehensive approach to evaluate the impact of HIV prevention interventions on risk behavior change and HIV seroconversion among PWIDs in Ukraine
    21 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level
  • New strategies to increase HIV case finding in hard to reach populations.
    21 July, 12:30-14:30, Exhibition Hall B, West Exhibition Level

Workshop: 20 July, 14:30-17:30

The concentrated HIV epidemic in Ukraine: effective strategies, results achieved and emerging challenges (Tanya Deshko, International HIV/AIDS Alliance in Ukraine)

Symposia session: 22 July, 16:30-18:00

Fuelling the epidemics: challenges facing HIV, HCV and OST programmes for PWID in Eastern Ukraine (Tanya Deshko, International HIV/AIDS Alliance in Ukraine)